Search
Supernus Pharmaceuticals Inc
SUPNAdd to Watchlist
27.620USD
+1.460+5.58%
Close 11-09 16:00（ET）
1.61BMarket Cap
LossP/E TTM
Supernus Pharmaceuticals Inc (SUPN) Stock Price Target & Forecast
Analyst Rating
Based on 5 analysts giving stock ratings to Supernus Pharmaceuticals Inc in the past month.
--
1 Strong Buy
3 Buy
1 Hold
0 Sell
0 Strong Sell
Target Price
61.600USD+46.95%
SUPN Analyst Recommendation Trends
In the current month, SUPN has received 3 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. SUPN average Analyst price target in the last month is 61.600.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
1
1
2
2
2
2
2
2
3
3
3
3
3
3
3
3
1
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5
5
6
6
6
6
6
6
SUPN Analyst Rating for Peer Comparison
Updated: Nov 5, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Biogen Inc
BIIB
8
16
12
1
0
37
Amgen Inc
AMGN
4
9
19
3
1
36
Eli Lilly and Co
LLY
10
19
3
1
0
33
Vertex Pharmaceuticals Inc
VRTX
10
17
5
0
1
33
Alnylam Pharmaceuticals Inc
ALNY
7
17
8
0
0
32
AbbVie Inc
ABBV
8
18
6
0
0
32
Merck & Co Inc
MRK
7
16
8
0
0
31
Neurocrine Biosciences Inc
NBIX
13
14
4
0
0
31
Gilead Sciences Inc
GILD
7
18
5
0
0
30
Bristol-Myers Squibb Co
BMY
5
6
18
1
0
30
Financial Forecasting
Based on analysts' estimates, SUPN EPS is projected to reach 1.020 in FY2026Q4, following reported EPS of 1.161 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
FY2027Q1
Forecast
0.30
0.36
0.49
1.02
0.85
Actual
-0.04
-1.01
1.16
--
--
Surprise
-113.37%
-382.35%
+136.94%
--
--
FAQs
What is Supernus Pharmaceuticals Inc's expected revenue for the next quarter?
Supernus Pharmaceuticals Inc's expected revenue is 230.79M.
What is Supernus Pharmaceuticals Inc's price target?
Analysts forecast that Supernus Pharmaceuticals Inc's price target is USD 61.60, with the highest forecast at USD 67.00 and the lowest forecast at USD 55.00.
How have Supernus Pharmaceuticals IncSUPN's recent earnings per share performed?
The market expectation was USD 1.16, while Supernus Pharmaceuticals IncSUPN's earnings per share (EPS) for the previous quarter was USD -1.01. EPS for the next quarter is expected at USD 1.02.